trending Market Intelligence /marketintelligence/en/news-insights/trending/S958XPAK8wBzXdAUfdGZ8g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Ampersand Capital Partners to buy Vibalogics

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

Latin American and Caribbean Market Considerations Blog Series: Focus on IFRS 9

Blog

COVID-19 Impact & Recovery: Private Equity

Blog

Banking Essentials Newsletter: April Edition - Part 2


Ampersand Capital Partners to buy Vibalogics

Middle-market private equity firm Ampersand Capital Partners is acquiring Vibalogics Gmbh for an undisclosed amount.

Vibalogics provides process development, manufacturing, and fill and finish of products for biopharmaceutical companies developing oncolytic viral therapies, gene therapies and vaccines.